Paying users zone. Data is hidden behind hidden.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

AbbVie Inc. (NYSE:ABBV)

Common-Size Balance Sheet: Assets

Beginner level

AbbVie Inc., common-size consolidated balance sheet: assets

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Cash and equivalents
Short-term investments
Accounts receivable, net
Inventories
Prepaid expenses and other
Current assets
Investments
Property and equipment, net
Intangible assets, net
Goodwill
Other assets
Long-term assets
Total assets

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. AbbVie Inc.’s current assets as a percentage of total assets decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. AbbVie Inc.’s property and equipment, net as a percentage of total assets increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. AbbVie Inc.’s long-term assets as a percentage of total assets increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.